05/15/2024
3:39 PM | Apogee Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/13/2024
6:10 AM | Apogee Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/13/2024
6:26 AM | Apogee Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
05/13/2024
6:05 AM | Apogee Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/24/2024
3:15 PM | Apogee Therapeutics (Filer)
| Form DEF 14A | |
04/24/2024
3:16 PM | Apogee Therapeutics (Filer)
| Form DEFA14A | |
04/24/2024
3:18 PM | Apogee Therapeutics (Filer)
| Form ARS | |
|
04/01/2024
4:42 PM | Apogee Therapeutics (Subject)
Fairmount Funds Management LLC (Filed by)
| Form SC 13D/A | |
04/01/2024
4:44 PM | Apogee Therapeutics (Issuer)
Fairmount Funds Management LLC (Reporting)
Fairmount Healthcare Fund II L.P. (Reporting)
Fairmount Healthcare Fund L.P. (Reporting)
Harwin Peter Evan (Reporting)
Kiselak Tomas (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/25/2024
6:30 AM | Apogee Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/11/2024
5:01 AM | Apogee Therapeutics (Filer)
| Form 424B4 | |
03/07/2024
11:15 PM | Apogee Therapeutics (Filer)
| Form EFFECT | |
03/07/2024
5:27 PM | Apogee Therapeutics (Filer)
| Form S-1MEF | |
03/05/2024
7:15 AM | Apogee Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/05/2024
5:11 AM | Apogee Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/05/2024
5:15 AM | Apogee Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/14/2024
7:35 AM | Apogee Therapeutics (Subject)
Deep Track Capital, LP (Filed by)
| Form SC 13G/A | |
02/09/2024
7:35 AM | Apogee Therapeutics (Subject)
FMR LLC (Filed by)
| Form SC 13G/A | |
01/31/2024
3:30 PM | Apogee Therapeutics (Subject)
Fairmount Funds Management LLC (Filed by)
| Form SC 13D/A | |
01/31/2024
3:31 PM | Apogee Therapeutics (Issuer)
Fairmount Funds Management LLC (Reporting)
Fairmount Healthcare Co-Invest II L.P. (Reporting)
Fairmount Healthcare Fund II L.P. (Reporting)
Fairmount Healthcare Fund L.P. (Reporting)
Harwin Peter Evan (Reporting)
Kiselak Tomas (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/20/2023
7:00 PM | Apogee Therapeutics (Issuer)
HENDERSON MICHAEL THOMAS (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/20/2023
7:00 PM | Apogee Therapeutics (Issuer)
Henderson Jane (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/20/2023
7:01 PM | Apogee Therapeutics (Issuer)
Dambkowski Carl (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/13/2023
6:41 AM | Apogee Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/13/2023
6:45 AM | Apogee Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/28/2023
7:38 AM | Apogee Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
08/28/2023
7:00 AM | Apogee Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/28/2023
6:35 AM | Apogee Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/21/2023
6:35 AM | Apogee Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/10/2023
7:19 AM | Apogee Therapeutics (Subject)
FMR LLC (Filed by)
| Form SC 13G | |
08/07/2023
6:35 AM | Apogee Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/24/2023
3:05 PM | Apogee Therapeutics (Subject)
Deep Track Capital, LP (Filed by)
| Form SC 13G | |
07/21/2023
3:31 PM | Apogee Therapeutics (Subject)
Fairmount Funds Management LLC (Filed by)
| Form SC 13D | |
07/17/2023
7:00 PM | Apogee Therapeutics (Issuer)
Fairmount Funds Management LLC (Reporting)
Fairmount Healthcare Co-Invest II L.P. (Reporting)
Fairmount Healthcare Fund II L.P. (Reporting)
Fairmount Healthcare Fund L.P. (Reporting)
Harwin Peter Evan (Reporting)
Kiselak Tomas (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/17/2023
7:00 PM | Apogee Therapeutics (Issuer)
Shah Nimish P (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/17/2023
7:01 PM | Apogee Therapeutics (Issuer)
Gottesdiener Andrew (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/17/2023
3:59 PM | Apogee Therapeutics (Issuer)
JONES WILLIAM A JR (Reporting)
| Form 3/A | |
07/17/2023
4:03 PM | Apogee Therapeutics (Issuer)
Fox Jennifer A. (Reporting)
| Form 3/A | |
07/17/2023
4:04 PM | Apogee Therapeutics (Issuer)
HENDERSON MICHAEL THOMAS (Reporting)
| Form 3/A | |
07/17/2023
4:05 PM | Apogee Therapeutics (Issuer)
Henderson Jane (Reporting)
| Form 3/A | |
07/17/2023
4:06 PM | Apogee Therapeutics (Issuer)
Dambkowski Carl (Reporting)
| Form 3/A | |
This is the best new way to score with AI (Ad) If you thought that you missed your chance to score big on AI, I have great news.
A rare second profit window is starting to open. Click now for the best way into the newest AI projects |
07/17/2023
3:08 PM | Apogee Therapeutics (Filer)
| Form 424B4 | |
07/13/2023
11:15 PM | Apogee Therapeutics (Filer)
| Form EFFECT | |
07/13/2023
5:39 PM | Apogee Therapeutics (Issuer)
Fairmount Funds Management LLC (Reporting)
Fairmount Healthcare Fund II L.P. (Reporting)
Fairmount Healthcare Fund L.P. (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
07/13/2023
5:39 PM | Apogee Therapeutics (Issuer)
Shah Nimish P (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
07/13/2023
5:40 PM | Apogee Therapeutics (Issuer)
Gottesdiener Andrew (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
07/13/2023
5:40 PM | Apogee Therapeutics (Issuer)
JONES WILLIAM A JR (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
07/13/2023
5:41 PM | Apogee Therapeutics (Issuer)
Fox Jennifer A. (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
07/13/2023
5:42 PM | Apogee Therapeutics (Issuer)
HENDERSON MICHAEL THOMAS (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
07/13/2023
5:42 PM | Apogee Therapeutics (Issuer)
Henderson Jane (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
07/13/2023
5:42 PM | Apogee Therapeutics (Issuer)
Dambkowski Carl (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
07/12/2023
12:13 PM | Apogee Therapeutics (Filer)
| Form CERT | |
07/10/2023
3:00 PM | Apogee Therapeutics (Filer)
| Form 8-A12B | |
07/10/2023
5:01 AM | Apogee Therapeutics (Filer)
| Form S-1/A | |
07/03/2023
3:44 PM | Apogee Therapeutics (Filer)
| Form S-1/A | |
06/22/2023
3:19 PM | Apogee Therapeutics (Filer)
| Form S-1
Registration statement under Securities Act of 1933 | |
